Literature DB >> 1605180

Sleep apnea in fragile X syndrome.

E Tirosh1, Z Borochowitz.   

Abstract

Seven subjects (age 6 to 21 years) with fragile X [fra(X)] were investigated for obstructive sleep apnea (OSA). After a structured interview, 4 of them underwent an overnight polygraphic study. The results indicate an increased risk for OSA among subjects with fra(X) (4/7). In 2 of the subjects polygraphic study indicated a severe OSA syndrome, whereas only mild and moderate severity was evident in the other two. Apnea in all 4 was associated with significant O2 desaturation. Episodes of prolonged expiratory apnea were reported in 2 of the subjects and confirmed by the polygraphic study in one. A continuous positive airway pressure (C-PAP) trial was successful in one of the two patients. It is suggested that subjects with fra(X) are at increased risk for OSA, and physicians should orientate their evaluation with this in mind.

Entities:  

Mesh:

Year:  1992        PMID: 1605180     DOI: 10.1002/ajmg.1320430119

Source DB:  PubMed          Journal:  Am J Med Genet        ISSN: 0148-7299


  3 in total

Review 1.  Fragile X syndrome: A review of clinical management.

Authors:  Reymundo Lozano; Atoosa Azarang; Tanaporn Wilaisakditipakorn; Randi J Hagerman
Journal:  Intractable Rare Dis Res       Date:  2016-08

2.  Feasibility of a Complex Setting for Assessing Sleep and Circadian Rhythmicity in a Fragile X Cohort.

Authors:  Alexander Dueck; Olaf Reis; Manuela Bastian; Lucas van Treeck; Steffen Weirich; Frank Haessler; Andreas Fiedler; Michael Koelch; Christoph Berger
Journal:  Front Psychiatry       Date:  2020-05-14       Impact factor: 4.157

3.  Polysomnographic Findings in Fragile X Syndrome Children with EEG Abnormalities.

Authors:  Marco Carotenuto; Michele Roccella; Francesco Pisani; Sara Matricardi; Alberto Verrotti; Giovanni Farello; Francesca Felicia Operto; Ilaria Bitetti; Francesco Precenzano; Giovanni Messina; Maria Ruberto; Cristiana Ciunfrini; Mariagrazia Riccardi; Eugenio Merolla; Grazia Maria Giovanna Pastorino; Anna Nunzia Polito; Rosa Marotta
Journal:  Behav Neurol       Date:  2019-12-03       Impact factor: 3.342

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.